2 domains / 4 areas / 2 specializations
IQVIA Real World Data
Also known as: IQVIA RWD
Data updated
Commercial real-world data products and linked evidence assets used in life sciences research and regulatory support.
Real-World Data Snapshot
Verification
Verified
Coverage
Global
Access Model
Paid / licensed access
Last Verified
Jul 13, 2026
Methodology
Data products are licensed and assembled from multiple healthcare data sources with proprietary curation pipelines.
Primary Dataset
View IQVIA RWDConsultancy & Advisory Snapshot
Market Access & HEOR ConsultingGeography
Global
Coverage
Global
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement
Monitoring-Only
Pipeline Stage Coverage
Client Types
Consultancy Notes
IQVIA is a global life sciences data and consulting company operating in more than 100 countries, with access to over 1.2 billion non-identified patient records used for real-world evidence, regulatory and payer support. Its psychedelic involvement is analytical rather than client-specific: a CNS white paper names psychedelics as one of four hot areas of CNS innovation and discusses regulatory momentum, IP, legalisation and reimbursement challenges. No dedicated psychedelic service line or named psychedelic client engagements are published.
Documented Engagements
CNS white paper covering psychedelic therapeutics
Deep dive on psychedelics as one of four hot areas of CNS innovation, covering regulatory stance of EMA and FDA, IP, legalisation, access and reimbursement challenges.
Two Steps Forward, One Step Back: The Long Road to Success in CNSSource Evidence
IQVIA official website
https://www.iqvia.com/
White paper: Two Steps Forward, One Step Back: The Long Road to Success in CNS
https://www.iqvia.com/-/media/iqvia/pdfs/library/white-papers/two-steps-forward-one-step-back-the-long-road-to-success-in-cns.pdf
The IQVIA Institute for Human Data Science
https://www.iqvia.com/insights/the-iqvia-institute
Quick Facts
- Website
- Visit